Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» stem cells
stem cells
Rudy Giuliani wants FDA to fast-track a stem cell therapy for Covid-19; critics see political meddling
STAT
Tue, 03/31/20 - 10:04 pm
Rudy Giuliani
politics
FDA
stem cells
COVID-19
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
Xtalks
Mon, 01/13/20 - 11:35 pm
stem cells
MS
multiple sclerosis
NIH
AHSCT
Biogen
Tysabri
Sanofi
Lemtrada
Roche
Ocrevus
Rituxan
Omeros hits endpoint in pivotal stem cell transplant study
Fierce Biotech
Wed, 12/4/19 - 09:58 am
Omeros
narsoplimab
stem cells
stem cell transplant
clinical trials
Stem Cell Therapy Works for Cardiac Patients, But Not in the Way We Think
Xtalks
Fri, 11/29/19 - 02:27 pm
stem cells
Cardiac
heart attack
ExCellThera launches trial of drug to expand umbilical cord blood for stem-cell transplants in cancer
Fierce Biotech
Wed, 11/6/19 - 05:16 pm
ExCellThera
umbilical cord blood
cord blood
stem cells
blood cancers
ReNeuron shares clinical data on stem cell vision loss therapy
Fierce Biotech
Mon, 10/14/19 - 09:56 am
ReNeuron
stem cells
Retinitis pigmentosa
vision loss
How Viagra could boost a widely used blood cancer treatment
Fierce Biotech
Thu, 10/10/19 - 12:59 pm
Viagra
Pfizer
stem cells
bone marrow
blood cancer
Sanofi
Mozobil
Lawmakers press Sharpless to bring stem cell companies into line
BioCentury
Sat, 07/27/19 - 02:00 pm
FDA
stem cells
Ned Sharpless
Takeda Receives 1st Stem Cell-Derived CAR-T From Kyoto University Collaboration
BioSpace
Tue, 07/16/19 - 12:02 pm
Takeda
Kyoto University
CAR-T
stem cells
Here's Why Athersys Is Soaring Today
Motley Fool
Tue, 04/23/19 - 11:01 pm
Athersys
Japan
clinical trials
stem cells
MultiStem
ARDS
Mesoblast poised to file cell therapy for GVHD in US
Pharmaforum
Wed, 04/17/19 - 09:44 am
Mesoblast
stem cells
graft vs host disease
FDA
remestemcel-L
Off-the-shelf CAR-T from stem cells? An early look at UCLA tech — licensed by Gilead
Endpoints
Thu, 02/21/19 - 10:47 pm
CAR-T
Gilead Sciences
UCLA
stem cells
Korean biotechs snatch U.S. stem cell manufacturing facility
Fierce Pharma
Thu, 02/14/19 - 12:11 am
Korea
stem cells
Daiichi Sankyo takes option on diabetes stem cell start-up
Pharmaforum
Sat, 01/12/19 - 11:30 am
Daiichi Sankyo
stem cells
Tokyo Institute of Technology
type 1 diabetes
OiDE BetaRevive
How Miniature Human Hearts Will Revolutionize Drug Testing
Forbes
Wed, 01/9/19 - 12:55 pm
drug safety
stem cells
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later
Xconomy
Thu, 11/29/18 - 12:15 am
ViaCyte
stem cells
diabetes
IPOs
clinical trials
Mesoblast defends stem cell therapy for heart failure after trial miss
Fierce Biotech
Wed, 11/14/18 - 10:01 am
Mesoblast
stem cells
clinical trials
heart failure
Magenta stem cell transplant drug seems to work, but is it safe?
Fierce Biotech
Thu, 11/1/18 - 12:20 pm
Magenta Therapeutics
MGTA-456
clinical trials
stem cells
NIH pauses stem cell trial after Brigham calls to retract 'fabricated' foundational research
BioCentury
Mon, 10/29/18 - 06:56 pm
NIH
stem cells
Brigham and Women's
FDA Grants Orphan Drug Designation to Omeros’ Treatment for Stem Cell Transplant-Associated Thrombotic Microangiopathy
CP Wire
Tue, 10/23/18 - 11:00 pm
Omeros
OMS721
stem cells
thrombotic microangiopathy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »